News | Ultrasound Imaging | September 08, 2023

Super resolution contrast-enhanced ultrasound (CEUS) application available on EPIQ Elite ultrasound system 

The introduction of a new contrast-enhanced ultrasound (CEUS) application on Philips EPIQ Elite helps enhance diagnostic confidence for cancer patients.

September 8, 2023 — When diagnosing and treating cancer patients, the dynamics of blood flow to and from a suspected lesion can provide clinicians with valuable diagnostic information. For example, blood flow through a liver tumor can offer insights into how likely it is that the cancer could spread. The current standard of care for assessing lesion blood flow requires the intravenous injection of an iodinated contrast media that is not well tolerated by some patients. In these instances, contrast-enhanced ultrasound (CEUS) is rapidly becoming a viable alternative as an increasingly important tool for lesion characterization.  

Instead of using an iodinated contrast media, CEUS leverages micro-bubble contrast media, based on an inert gas that is excreted via the patient’s breathing. With the introduction of Philips Microvascular Imaging Super Resolution Contrast-Enhanced Ultrasound (CEUS) on Philips Ultrasound System – EPIQ Elite – CEUS imaging now delivers up to 200% better spatial resolution than previous offerings.  

“Philips’ microvascular imaging allows us to visualize the pattern of contrast media flow into a lesion, and also shows how it changes over time, which gives us greater diagnostic confidence in assessing indeterminate lesions,” said Professor Dirk-André Clevert, Professor of Radiology at Ludwig-Maximilians-Universität (LMU), Munich, Germany. “Sharing our knowledge about how to use this latest technology and interpret the results has been greatly enhanced by Philips’ latest Collaboration Live software [1], which allows us to remotely train external sonographers and guide them through procedures.”   

Delivering exceptional detail and enhanced patient safety 

Like other CEUS modalities, super resolution microvascular imaging (MVI) does not expose patients to ionizing radiation and is generally more cost-effective and more accessible. Compared to iodinated contrast media, adverse reaction rates to the micro-bubble contrast media used for CEUS are also much lower.  

EPIQ Elite is a premium ultrasound system that combines the latest advances in transducer innovation and enhanced performance to help improve clinical confidence and deliver personalized care for patients. Featuring a wide range of multiple diagnostic applications and tools tailored to meet the needs of specific medical specialties, EPIQ Elite offers exceptional levels of clinical performance combined with the workflow efficiency needed to meet the challenges of today’s demanding practices. 

Philips Ultrasound System – EPIQ Elite – with Microvascular Imaging Super Resolution CEUS is being showcased by Philips at the International Bubble Conference (September 7-8, 2023, Chicago, USA), where Professor Clevert will give a presentation titled ‘New Super Resolution MVI and Time of Arrival Imaging (TOA) in the Characterization of Liver Lesions.’ Visit Philips EPIQ Elitefor more information on Philips premium ultrasound.  

For more information: www.philips.com 

Reference: 

[1] Contract required. Collaboration Live is intended for remote diagnostic use on release 9 or higher.


Related Content

News | ASTRO

October 1, 2023 — The 2023 Abstract Award winners have been announced by the American Society for Radiation Oncology ...

Time October 01, 2023
arrow
News | Women's Health

October 1, 2023 — In a first-of-its-kind study, people with breast cancer who underwent implant-based breast ...

Time October 01, 2023
arrow
News | Stereotactic Body Radiation Therapy (SBRT)

October 1, 2023 — Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted ...

Time October 01, 2023
arrow
News | Women's Health

October 1, 2023 — People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical ...

Time October 01, 2023
arrow
News | Information Technology

September 29, 2023 — Fuse Oncology (Fuse) a trailblazing leader in radiation oncology software solutions, unveils their ...

Time September 29, 2023
arrow
News | Prostate Cancer

September 29, 2023 — People with intermediate risk, localized prostate cancer can be treated as effectively using fewer ...

Time September 29, 2023
arrow
News | Oncology Information Management Systems (OIMS)

September 29, 2023 — RaySearch will be showcasing the latest software innovations at ASTRO in San Diego, California ...

Time September 29, 2023
arrow
News | Radiation Therapy

September 29, 2023 — Varian, a Siemens Healthineers company, is showcasing technologies that reflect its continued ...

Time September 29, 2023
arrow
News | Proton Therapy

September 28, 2023 — Mevion Medical Systems, the leading provider of compact single-room proton therapy systems, will ...

Time September 28, 2023
arrow
News | Radiation Therapy

September 28, 2023 — RefleXion Medical, a therapeutic oncology company, announced the company will showcase the ...

Time September 28, 2023
arrow
Subscribe Now